Annual Accounts Payable
$1.92 M
-$317.00 K-14.16%
31 December 2023
Summary:
Adverum Biotechnologies annual accounts payable is currently $1.92 million, with the most recent change of -$317.00 thousand (-14.16%) on 31 December 2023. During the last 3 years, it has fallen by -$889.00 thousand (-31.64%). ADVM annual accounts payable is now -53.18% below its all-time high of $4.10 million, reached on 31 December 2019.ADVM Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$2.11 M
+$137.00 K+6.94%
30 September 2024
Summary:
Adverum Biotechnologies quarterly accounts payable is currently $2.11 million, with the most recent change of +$137.00 thousand (+6.94%) on 30 September 2024. Over the past year, it has dropped by -$60.00 thousand (-2.76%). ADVM quarterly accounts payable is now -79.65% below its all-time high of $10.37 million, reached on 30 June 2020.ADVM Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADVM Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.2% | -2.8% |
| 3 y3 years | -31.6% | -16.2% |
| 5 y5 years | +12.5% | -37.6% |
ADVM Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -31.6% | +38.5% | -55.1% | +149.4% |
| 5 y | 5 years | -53.2% | +38.5% | -79.7% | +149.4% |
| alltime | all time | -53.2% | +268.0% | -79.7% | +334.2% |
Adverum Biotechnologies Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.11 M(+6.9%) |
| June 2024 | - | $1.97 M(+4.0%) |
| Mar 2024 | - | $1.90 M(-1.2%) |
| Dec 2023 | $1.92 M(-14.2%) | $1.92 M(-11.5%) |
| Sept 2023 | - | $2.17 M(+53.0%) |
| June 2023 | - | $1.42 M(-50.5%) |
| Mar 2023 | - | $2.86 M(+27.9%) |
| Dec 2022 | $2.24 M(+61.4%) | $2.24 M(+164.5%) |
| Sept 2022 | - | $846.00 K(-82.0%) |
| June 2022 | - | $4.70 M(+44.8%) |
| Mar 2022 | - | $3.25 M(+134.0%) |
| Dec 2021 | $1.39 M(-50.6%) | $1.39 M(-44.9%) |
| Sept 2021 | - | $2.52 M(+11.4%) |
| June 2021 | - | $2.26 M(+9.9%) |
| Mar 2021 | - | $2.06 M(-26.8%) |
| Dec 2020 | $2.81 M(-31.5%) | $2.81 M(-7.4%) |
| Sept 2020 | - | $3.03 M(-70.7%) |
| June 2020 | - | $10.37 M(+122.3%) |
| Mar 2020 | - | $4.66 M(+13.6%) |
| Dec 2019 | $4.10 M | $4.10 M(+21.3%) |
| Sept 2019 | - | $3.38 M(+357.0%) |
| June 2019 | - | $740.00 K(-57.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $1.75 M(+2.6%) |
| Dec 2018 | $1.71 M(-1.4%) | $1.71 M(-1.7%) |
| Sept 2018 | - | $1.74 M(-18.3%) |
| June 2018 | - | $2.13 M(+210.2%) |
| Mar 2018 | - | $685.00 K(-60.4%) |
| Dec 2017 | $1.73 M(+17.4%) | $1.73 M(+9.6%) |
| Sept 2017 | - | $1.58 M(+40.4%) |
| June 2017 | - | $1.13 M(-66.7%) |
| Mar 2017 | - | $3.38 M(+129.5%) |
| Dec 2016 | $1.47 M(+143.6%) | $1.47 M(-51.9%) |
| Sept 2016 | - | $3.07 M(+26.8%) |
| June 2016 | - | $2.42 M(+397.7%) |
| Mar 2016 | - | $486.00 K(-19.7%) |
| Dec 2015 | $605.00 K(-36.4%) | $605.00 K(-47.0%) |
| Sept 2015 | - | $1.14 M(-39.8%) |
| June 2015 | - | $1.90 M(-32.0%) |
| Mar 2015 | - | $2.79 M(+193.1%) |
| Dec 2014 | $951.00 K(+23.7%) | $951.00 K(-41.5%) |
| Sept 2014 | - | $1.63 M(+3.2%) |
| June 2014 | - | $1.58 M(+66.6%) |
| Mar 2014 | - | $946.00 K(+23.0%) |
| Dec 2013 | $769.00 K(+47.3%) | $769.00 K |
| Dec 2012 | $522.00 K | - |
FAQ
- What is Adverum Biotechnologies annual accounts payable?
- What is the all time high annual accounts payable for Adverum Biotechnologies?
- What is Adverum Biotechnologies annual accounts payable year-on-year change?
- What is Adverum Biotechnologies quarterly accounts payable?
- What is the all time high quarterly accounts payable for Adverum Biotechnologies?
- What is Adverum Biotechnologies quarterly accounts payable year-on-year change?
What is Adverum Biotechnologies annual accounts payable?
The current annual accounts payable of ADVM is $1.92 M
What is the all time high annual accounts payable for Adverum Biotechnologies?
Adverum Biotechnologies all-time high annual accounts payable is $4.10 M
What is Adverum Biotechnologies annual accounts payable year-on-year change?
Over the past year, ADVM annual accounts payable has changed by -$317.00 K (-14.16%)
What is Adverum Biotechnologies quarterly accounts payable?
The current quarterly accounts payable of ADVM is $2.11 M
What is the all time high quarterly accounts payable for Adverum Biotechnologies?
Adverum Biotechnologies all-time high quarterly accounts payable is $10.37 M
What is Adverum Biotechnologies quarterly accounts payable year-on-year change?
Over the past year, ADVM quarterly accounts payable has changed by -$60.00 K (-2.76%)